JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 1993; 21:1152-1157
© 1993 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by el-Tamimi, H
Right arrow Articles by Maseri, A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by el-Tamimi, H
Right arrow Articles by Maseri, A

Response of human coronary arteries to acetylcholine after injury by coronary angioplasty

H el-Tamimi, GJ Davies, F Crea, and A Maseri

Division of Cardiology, University of Florida, Gainesville 32610-0277.

OBJECTIVES. The aim of this study was to investigate the effect of intracoronary administration of acetylcholine on large epicardial vessels 8 days after successful coronary angioplasty. BACKGROUND. Intracoronary infusion of acetylcholine causes vessel dilation in patients without angiographic evidence of coronary atherosclerosis, whereas it causes constriction of stenotic coronary branches. These findings were interpreted as evidence of endothelial dysfunction in patients with coronary atherosclerosis. METHODS. Eight patients who underwent successful single-vessel coronary angioplasty of the proximal left anterior descending artery were studied. Eight days after coronary angioplasty at the time of follow-up coronary angiography, intracoronary acetylcholine was infused (1 ml/min for 2 min) at concentrations ranging from 10(-7) to 10(-4) mol/liter. The diameter of the angioplasty and distal segments of the left anterior descending artery and that of the proximal and distal segments of the circumflex artery (control artery) were measured using computerized edge detection angiography. RESULTS. All patients showed a dose-dependent constriction in response to acetylcholine and experienced chest pain and ST segment changes. Intracoronary nitroglycerin (300 micrograms) relieved the effects of acetylcholine. The maximal tolerated dose of acetylcholine (10(-6) mol/liter in three patients, 10(-5) mol/liter in three patients and 10(-4) mol/liter in two patients) induced a mild constriction of the angioplasty segment from 1.84 +/- 0.11 mm to 1.52 +/- 0.13 mm (p < 0.02) similar to that of the proximal segment of the control artery (from 2.42 +/- 0.23 to 2.07 +/- 0.19 mm, p < 0.02). However, the degree of constriction of the vascular segments distal to the angioplasty site (from 1.24 +/- 0.09 to 0.62 +/- 0.13 mm, p < 0.01) was significantly greater (p < 0.05) than that observed in the distal segments of the control artery (from 1.23 +/- 0.03 to 0.71 +/- 0.01 mm, p < 0.01) and resulted in transient total occlusion in two patients. CONCLUSIONS. Eight days after coronary angioplasty, coronary segments distal to the dilated site but not at the dilated site are hyperreactive to acetylcholine. The response of epicardial coronary arteries to acetylcholine is influenced not only by the dose of acetylcholine and the endothelial function (as currently believed) but also by the location of the coronary segment considered, confirming the presence of a profound alteration of distal coronary vessels.


This article has been cited by other articles:


Home page
Vasc MedHome page
R. H Boger
Asymmetric dimethylarginine (ADMA) and cardiovascular disease: insights from prospective clinical trials
Vascular Medicine, July 1, 2005; 10(1_suppl): S19 - S25.
[Abstract] [PDF]


Home page
Vasc MedHome page
R. H Boger
Asymmetric dimethylarginine (ADMA) and cardiovascular disease: insights from prospective clinical trials
Vascular Medicine, May 1, 2005; 10(2_suppl): S19 - S25.
[Abstract] [PDF]


Home page
J. Nutr.Home page
R. H. Boger
Asymmetric Dimethylarginine, an Endogenous Inhibitor of Nitric Oxide Synthase, Explains the "L-Arginine Paradox" and Acts as a Novel Cardiovascular Risk Factor
J. Nutr., October 1, 2004; 134(10): 2842S - 2847S.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. D. Aymong, M. J. Curtis, M. Youssef, M. M. Graham, L. Shewchuk, W. Leschuk, and T. J. Anderson
Abciximab Attenuates Coronary Microvascular Endothelial Dysfunction After Coronary Stenting
Circulation, June 25, 2002; 105(25): 2981 - 2985.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Sabate, I. P. Kay, W. J. van der Giessen, A. Cequier, J. M. R. Ligthart, J. A. Gomez-Hospital, S. G. Carlier, V. L. M. A. Coen, J. P. A. Marijnissen, A. J. Wardeh, et al.
Preserved Endothelium-Dependent Vasodilation in Coronary Segments Previously Treated With Balloon Angioplasty and Intracoronary Irradiation
Circulation, October 12, 1999; 100(15): 1623 - 1629.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Albertal, M. Voskuil, J.J. Piek, B. de Bruyne, G. Van Langenhove, P.I. Kay, M.A. Costa, E. Boersma, T. Beijsterveldt, J.E. Sousa, et al.
Coronary Flow Velocity Reserve After Percutaneous Interventions Is Predictive of Periprocedural Outcome
Circulation, April 2, 2002; 105(13): 1573 - 1578.
[Abstract] [Full Text] [PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 1993 by the American College of Cardiology Foundation.